PlainRecalls
FDA Drug Moderate Class II Ongoing

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

Reported: July 9, 2025 Initiated: June 2, 2025 #D-0500-2025

Product Description

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

Reason for Recall

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Details

Recalling Firm
Tailstorm Health INC
Units Affected
23,200 vials
Distribution
Nationwide in the US
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.. Recalled by Tailstorm Health INC. Units affected: 23,200 vials.
Why was this product recalled?
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 9, 2025. Severity: Moderate. Recall number: D-0500-2025.